Goldman Sachs analyst Evie Koslosky initiates coverage on Caris Life Sciences Inc (NASDAQ: CAI) with a Buy rating and a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage